Cargando…
P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428875/ http://dx.doi.org/10.1097/01.HS9.0000969396.26114.b3 |
| _version_ | 1785090575027929088 |
|---|---|
| author | Al-Sawaf, Othman Jen, Min-Hua Hess, Lisa Zhang, Jiewen Goebel, Benjamin Pagel, John Eyre, Toby |
| author_facet | Al-Sawaf, Othman Jen, Min-Hua Hess, Lisa Zhang, Jiewen Goebel, Benjamin Pagel, John Eyre, Toby |
| author_sort | Al-Sawaf, Othman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428875 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288752023-08-17 P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR Al-Sawaf, Othman Jen, Min-Hua Hess, Lisa Zhang, Jiewen Goebel, Benjamin Pagel, John Eyre, Toby Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428875/ http://dx.doi.org/10.1097/01.HS9.0000969396.26114.b3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Al-Sawaf, Othman Jen, Min-Hua Hess, Lisa Zhang, Jiewen Goebel, Benjamin Pagel, John Eyre, Toby P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_full | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_fullStr | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_full_unstemmed | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_short | P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITOR |
| title_sort | p623: matching-adjusted indirect comparison (maic) of pirtobrutinib vs venetoclax continuous monotherapy in patients with relapsed/refractory cll previously treated with a covalent btk inhibitor |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428875/ http://dx.doi.org/10.1097/01.HS9.0000969396.26114.b3 |
| work_keys_str_mv | AT alsawafothman p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT jenminhua p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT hesslisa p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT zhangjiewen p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT goebelbenjamin p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT pageljohn p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor AT eyretoby p623matchingadjustedindirectcomparisonmaicofpirtobrutinibvsvenetoclaxcontinuousmonotherapyinpatientswithrelapsedrefractorycllpreviouslytreatedwithacovalentbtkinhibitor |